Kyohei Watanabe

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.

Hideo Kunitoh, Kyohei Watanabe, T Onoshi et al. · Journal of Clinical Oncology · 1996 · 136 citations

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

Kiyoshi Takasuna, Toshihiko Hagiwara, Kyohei Watanabe et al. · Cancer Chemotherapy and Pharmacology · 2006 · 77 citations

Health Sciences, Gastrointestinal Oncology, Optimal Antidiarrhea Treatment +7

The Inhibitory Effect of Ciprofloxacin on the β‐Glucuronidase‐mediated Deconjugation of the Irinotecan Metabolite SN‐38‐G

Takaaki Kodawara, T. Higashi, Yutaka Negoro et al. · Basic & Clinical Pharmacology & Toxicology · 2015 · 38 citations

Complete response to combination therapy with nivolumab and ipilimumab for metastatic collecting duct carcinoma of the kidney

Kyohei Watanabe, Takayuki Sugiyama, Atsushi Otsuka et al. · International Cancer Conference Journal · 2019 · 32 citations · Full text

Urology, Surgical Oncology, Oncology +10